Mederi Therapeutics Unveils Stretta System In US
Mederi said that the Stretta Therapy delivers radiofrequency (RF) energy to the muscles of the Lower esophageal sphincter (LES), the valve that separates the stomach from the esophagus.
Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at treating adult patients with extensive-stage small cell lung cancer (ES-SCLC) following disease progression after platinum-based chemotherapy.